Bacillus subtilis strains improving animal performance parameters

Patent metadata

Field	Value
Publication number	US-11291695-B2
Application number	US-201816492897-A
Country	US
Kind code	B2
Filing date	Mar 14, 2018
Priority date	Mar 14, 2017
Publication date	Apr 5, 2022
Grant date	Apr 5, 2022

Abstract

The present invention provides a Bacillus subtilis strain selected from the group consisting of a) the strain deposited as DSM32324, b) the strain deposited as DSM32325, and c) a mutant strain of (a) or (b) which has sensitivity for ampicillin, vancomycin, gentamicin, kanamycin, streptomycin, erythromycin, clindamycin, tetracycline, and chloramphenicol; and has inhibitory activity against E. coli and Clostridium perfringens. The invention further relates to Bacillus compositions comprising at least one Bacillus subtilis strain of the invention, preferably the Bacillus subtilis strain DSM32324 and/or the Bacillus subtilis strain DSM32325, as Direct Fed Microbial (DFM), premix, animal feed additive or animal feed. The invention provides a method of improving one or more animal performance parameters selected from the group consisting of i) increased weight gain (WG), ii) lower feed conversion ratio (FCR), iii) lower necrotic enteritis lesion scoring, iv) lower necrotic enteritis frequency, v) lower necrotic enteritis mortality, vi) increased European Production Efficacy Factor (EPEF), and vii) lower mortality, by feeding a strain or a composition according to the invention to an animal.

First claim

The invention claimed is:

1. An animal feed, animal feed additive, or animal feed premix composition with improved resistance to growth of Escherichia coli and Clostridium perfringens comprising:
(i) from 10 5 to 10 12 colony forming units per gram (CFU/g) of at least one Bacillus subtilis strain selected from:
(a) the strain deposited at Deutsche Sammlung von Mikroorganismen and Zellkulturen GmbH (DSMZ) under accession number DSM32324, and
(b) the strain deposited at DSMZ under accession number DSM32325,
and

(ii) one or more animal feed, animal feed additive, or animal feed premix ingredients,
wherein the at least one Bacillus strains is effective to inhibit growth of Escherichia coli and Clostridium perfringens.

2. The composition according to claim 1 , wherein the at least one Bacillus subtilis strain comprises the Bacillus subtilis strain deposited at DSMZ under accession number DSM32324.

3. The composition according to claim 1 , wherein the at least one Bacillus subtilis strain comprises the Bacillus subtilis strain deposited at DSMZ under accession number DSM32325.

4. The composition according to claim 1 , wherein the at least one Bacillus subtilis strain comprises the Bacillus subtilis strain deposited at DSMZ under accession number DSM32324 and the Bacillus subtilis strain deposited at DSMZ under accession number DSM32325.

5. The composition according to claim 1 , wherein the at least one Bacillus strain is present as spores.

6. The composition according to claim 1 , which is an animal feed additive.

7. A method for control of bacterial colonization or infection by Escherichia coli or Clostridium perfringens , the method comprising administering an effective amount of a composition according to claim 1 to an animal in need thereof.

8. A method of improving one or more animal performance parameters selected from weight gain (WG), feed conversion ratio (FCR), necrotic enteritis lesion scoring, necrotic enteritis frequency, necrotic enteritis mortality, European Production Efficacy Factor (EPEF), and mortality, comprising feeding a composition according to claim 1 to an animal.

9. The composition according to claim 1 , wherein the one or more animal feed, animal feed additive, or animal feed premix ingredients comprises forage, milk, or a milk replacement.

10. The composition according to claim 1 , wherein the one or more animal feed, animal feed additive, or animal feed premix ingredients comprises one or more selected from vitamin(s), mineral(s), enzyme(s), and amino acid(s).

11. The composition according to claim 1 , wherein the one or more animal feed, animal feed additive, or animal feed premix ingredients comprises one or more carriers selected from glycerol, ethylene glycol, 1,2-propylene glycol, 3-propylene glycol, sodium chloride, sodium benzoate, potassium sorbate, sodium sulfate, potassium sulfate, magnesium sulfate, sodium thiosulfate, calcium carbonate, sodium citrate, dextrin, maltodextrin, glucose, sucrose, sorbitol, lactose, whey, whey permeate, wheat flour, wheat bran, corn gluten meal, starch, and cellulose.

12. A method for feeding an animal comprising administering a Bacillus subtilis strain to an animal, wherein the Bacillus subtilis strain is selected from:
(a) the strain deposited at Deutsche Sammlung von Mikroorganismen and Zellkulturen GmbH (DSMZ) under accession number DSM32324, and
(b) the strain deposited at DSMZ under accession number DSM32325.

13. The method of claim 12 , wherein the Bacillus subtilis strain is administered in an amount effective to control bacterial colonization or infection by Escherichia coli or Clostridium perfringens in the animal.

14. The method of claim 12 , further comprising feeding the animal an animal feed, wherein the method is effective for increasing digestibility of the animal feed.

15. The method of claim 12 , wherein the Bacillus subtilis strain is administered in an amount effective to improve one or more animal performance parameters selected from the group consisting of
(i) increased weight gain (WG),
(ii) lower feed conversion ratio (FCR),
(iii) lower necrotic enteritis lesion scoring,
(iv) lower necrotic enteritis frequency,
(v) lower necrotic enteritis mortality,
(vi) increased European Production Efficacy Factor (EPEF), and
(vii) lower mortality.

16. The method according to claim 12 , wherein the animal is an animal selected from the group consisting of poultry, horses, ruminants, swine, rodents, fish and crustaceans.

17. A method of increasing digestibility of an animal feed, comprising adding a Bacillus subtilis strain to an animal feed, wherein the Bacillus subtilis strain is selected from:
(a) the strain deposited at Deutsche Sammlung von Mikroorganismen and Zellkulturen GmbH (DSMZ) under accession number DSM32324, and
(b) the strain deposited at DSMZ under accession number DSM32325.

Assignees

• Chr Hansen As

Inventors

• Sandvang Dorthe
• Styrishave Tina

Classifications

• A23K20/189 Primary

  Enzymes · CPC title

• A23K50/75

  for poultry · CPC title

• A61K9/0053

  Mouth and digestive tract, i.e. intraoral and peroral administration · CPC title

• A23K10/16

  Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions (A23K10/12 takes precedence) · CPC title

• C12R2001/125

  Bacillus subtilis {; Hay bacillus; Grass bacillus} · CPC title